Antineoplastic Cytotoxicity and Immune Adjuvancy of a Recombinant Oncolytic Poliovirus

dc.contributor.advisor

Gromeier, Matthias

dc.contributor.author

Brown, Michael Clavon

dc.date.accessioned

2016-06-06T14:36:14Z

dc.date.available

2018-04-13T08:17:13Z

dc.date.issued

2016

dc.department

Molecular Genetics and Microbiology

dc.description.abstract

Our group has pioneered the development of a live-attenuated poliovirus, called PVSRIPO, for the purpose of targeting cancer. Despite clinical progress, the cancer selective cytotoxicity and immunotherapeutic potential of PVSRIPO has not yet been mechanistically dissected. Defining such mechanisms may inform its clinical application.

Herein I describe the discovery of a mechanism by which the MAP-Kinase Interacting Kinases (MNKs) regulate PVSRIPO cytotoxicity in cancer. In doing so, I delineate a novel, intricate network connecting the MNK and mTOR signaling pathway that regulates activity of a splicing kinase called the Ser-Arg Rich Protein Kinase (SRPK), and define SRPK as an impediment to IRES mediated translation. Moreover, I demonstrate that MNK regulates mTORC1 associations that determine its substrate proximity and thus, activity. In a collaborative effort, we found that PVSRIPO oncolysis produces antigen specific, cytolytic anti-tumor immunity in an in vitro human system and that much of the observed adjuvancy is due to the direct infection of dendritic cells (DCs) by the virus itself; implicating PVSRIPO as a potent adjuvant. In summary, oncogenic signaling in part through MNK leads to cancer specific cytotoxicity by PVSRIPO that engages an inflammatory environment conducive to DC activation and antigen specific T cell antigen immunity.

dc.identifier.uri

https://hdl.handle.net/10161/12133

dc.subject

Molecular biology

dc.subject

Biochemistry

dc.subject

Antigen Presentation

dc.subject

Immunotherapy

dc.subject

IRES

dc.subject

MNK

dc.subject

Oncoltyic virus

dc.subject

SRPK

dc.title

Antineoplastic Cytotoxicity and Immune Adjuvancy of a Recombinant Oncolytic Poliovirus

dc.type

Dissertation

duke.embargo.months

22

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Brown_duke_0066D_13304.pdf
Size:
6.33 MB
Format:
Adobe Portable Document Format

Collections